Is TuHURA Biosciences, Inc./NV a real, registered company?
TuHURA Biosciences, Inc./NV is a registered filer with the SEC (CIK 1498382) and has filed since 2025-06-13. 2 filings are on record, the latest on 2025-11-10.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Who runs TuHURA Biosciences, Inc./NV?
TuHURA Biosciences, Inc./NV's filings name Alan List, Craig Tendler, Dan Dearborn and 4 more as its officers, directors or promoters.
How much has TuHURA Biosciences, Inc./NV raised?
Its new offerings report $3.73M sold across 2 offerings, as its own filings state.
Run the free check on TuHURA Biosciences, Inc./NV →
TAMPA, FLORIDA
Biotechnology
2
$3.73M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2025-11-10 | New offering first sale 2025-10-27 | $1.50M | $3M | details · SEC filing |
| 2025-06-13 | New offering first sale 2025-06-02 | $2.23M | $12.61M | details · SEC filing |
Want the whole picture on TuHURA Biosciences, Inc./NV?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on TuHURA Biosciences, Inc./NV: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on TuHURA Biosciences, Inc./NV covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from TuHURA Biosciences, Inc./NV's own filings with the SEC. The people those filings name are on the team page.

